Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Toungoussova, O."'
Autor:
Migliori, G. B., Lange, C., Centis, R., Sotgiu, G., Mutterlein, R., Hoffmann, H., Kliiman, K., De Iaco, G., Lauria, F. N., Richardson, M. D., Spanevello, A., Cirillo, D. M., Ortmann, J., Kirsten, D., Ruesch Gerdes, S., Piana, F., Gori, A., Codecasa, L. R., Ferrarese, M., Toungoussova, O. S., Ferrara, Giovanni, Matteelli, A., De Lorenzo, S., Troupioti, P., Besozzi, G., Fattorini, L., Iona, E., Gualano, A., De Mori, P., Bevilacqua, N., Girardi, E., Danilovits, M., Hollo, V., Mariandyshev, A.
Publikováno v:
European Respiratory Journal. 31:1155-1159
No information is currently available on the influence of injectable second-line drugs on treatment outcomes of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) patients. To investigate this issue, a large series of MD
Autor:
Sotgiu, G, Ferrara, Giovanni, Matteelli, A, Richardson, M, Centis, R, RUESCH GERDES, S, Toungoussova, O, Zellweger, J, Spanevello, A, Cirillo, D, Lange, C, Migliori, G.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3982::973f9c2ca1c52ad5b848b87fd1873dd3
http://hdl.handle.net/11391/126392
http://hdl.handle.net/11391/126392
Autor:
Migliori, G. B., Eker, B., Richardson, M. D., Sotgiu, G., Zellweger, J. P., Skrahina, A., Ortmann, J., Girardi, E., Hoffmann, H., Besozzi, G., Bevilacqua, N., Kirsten, D., Centis, R., Lange, C., Hurevich, H, Skrahin, A, Muetterlein, R, Schaberg, T, Eberhardt, R, Flick, H, de Roux, A, Hamm, M, Hang, H, Hannemann, P, Hillemann, D, Kretz, B, Laumanns, C, Paulick, A, Pletz, Mw, Rau, M, Schaudt, C, Matteelli, A, Spanevello, Antonio, Toungoussova, O, D'Ambrosio, L, De Lorenzo, S, Troupioti, P, De Iaco, G, Gualano, A, De Mori, P, Lauria, Fn, Ferrara, G, Cirillo, D, Janssens, J. P.
Linezolid is used to treat patients with multidrug-resistant (MDR)/extensively drug-resistant (XDR)-tuberculosis (TB) cases, although clinical data on its safety, tolerability and efficacy are lacking. We performed a retrospective, nonrandomised, unb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b1a1cfb92248f896e9b44811345f582
http://hdl.handle.net/11383/1827519
http://hdl.handle.net/11383/1827519
Autor:
Migliori, G. B., Lange, C., Girardi, E., Centis, R., Besozzi, G., Kliiman, K., Ortmann, J., Matteelli, A., Spanevello, A., Cirillo, D. M., Kirsten, D., Codecasa, L. R., Gori, A., De Lorenzo, S., Troupioti, P., De Iaco, G., Gualano, G., De Mori, P., Fattorini, L., Iona, E., Ferrara, G., Sotgiu, G., Danilovits, M., Hollo, V., Mariandyshev, A., Toungoussova, O.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e23f2fc4be585ec23c659f43b162515
http://hdl.handle.net/11383/8818
http://hdl.handle.net/11383/8818
Autor:
Toungoussova, O., Foschino Barbaro, M. P., Esposito, L. M., Carpagnano, G. E., Salerno, F. G., Dal Negro, R. W., ANTONIO SPANEVELLO
Publikováno v:
Monaldi Archives for Chest Disease, Vol 67, Iss 2 (2016)
Scopus-Elsevier
Scopus-Elsevier
Brittle asthma is a clinical phenotype of the disease at the severe end of the spectrum. Type 1 brittle asthma is characterised by a maintained wide PEF variability (> 40% diurnal variation for > 50% of the time over a period of at least 150 days) de
Autor:
Migliori, G., Besozzi, G., Kliiman, K., Lange, C., Toungoussova, O., Ferrara, Giovanni, Cirillo, D., Gori, A., Matteelli, A., Spanevello, A., Codecasa, L., Raviglione, M.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3982::e4b6d532a24c3cf7ec5d8fe01d014b94
http://hdl.handle.net/11391/163346
http://hdl.handle.net/11391/163346
Autor:
Migliori, G. B., Besozzi, G., Girardi, E., Kliiman, K., Lange, C., Toungoussova, O. S., Ferrara, G., Cirillo, D. M., Gori, A., Matteelli, A., Spanevello, A., Codecasa, L. R., Raviglione, M. C., Ortmann, J., Kirsten, D., Ruesch-Gerdes, S., Piana, F., Ferrarese, M., De Iaco, G., De Lorenzo, S., Troupioti, P., Fattorini, L., Iona, E., Gualano, A., De Mori, P., Centis, R., Danilovits, M., Hollo, V., Mariandyshev, A.
Publikováno v:
Karolinska Institutet
Currently, no information is available on the effect of resistance/susceptibility to first-line drugs different from isoniazid and rifampicin in determining the outcome of extensively drug-resistant tuberculosis (XDR-TB) patients, and whether being X
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b6c3d5e076b3be05fe66a9ab0282014
http://hdl.handle.net/11379/533284
http://hdl.handle.net/11379/533284
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.